Filing Details

Accession Number:
0000950170-25-049717
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-02 18:29:36
Reporting Period:
2025-03-31
Filing Date:
2025-04-02
Accepted Time:
2025-04-02 18:29:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607678 Viking Therapeutics Inc. VKTX Pharmaceutical Preparations (2834) 461073877
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761366 Kathryn Sarah Rouan C/O Viking Therapeutics, Inc.
9920 Pacific Heights Blvd, Suite 350
San Diego CA 92121
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.00001 Per Share Acquisiton 2025-03-31 1,240 $24.15 1,240 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct